Credit Suisse’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $176K | Buy |
+15,765
| New | +$176K | ﹤0.01% | 2902 |
|
|
2023
Q2 | – | Sell |
-21,297
| Closed | -$96.3K | – | 3151 |
|
|
2023
Q1 | $96.3K | Buy |
21,297
+4
| +0% | +$18 | ﹤0.01% | 3193 |
|
|
2022
Q4 | $240K | Sell |
21,293
-4,940
| -19% | -$55.7K | ﹤0.01% | 3107 |
|
|
2022
Q3 | $250K | Buy |
26,233
+11,076
| +73% | +$106K | ﹤0.01% | 3139 |
|
|
2022
Q2 | $121K | Buy |
15,157
+940
| +7% | +$7.5K | ﹤0.01% | 3481 |
|
|
2022
Q1 | $240K | Buy |
14,217
+383
| +3% | +$6.47K | ﹤0.01% | 3306 |
|
|
2021
Q4 | $297K | Buy |
13,834
+9,456
| +216% | +$203K | ﹤0.01% | 3295 |
|
|
2021
Q3 | $324K | Buy |
4,378
+271
| +7% | +$20.1K | ﹤0.01% | 3225 |
|
|
2021
Q2 | $224K | Sell |
4,107
-2,026
| -33% | -$111K | ﹤0.01% | 3397 |
|
|
2021
Q1 | $452K | Sell |
6,133
-7,411
| -55% | -$546K | ﹤0.01% | 3012 |
|
|
2020
Q4 | $1.17M | Buy |
+13,544
| New | +$1.17M | ﹤0.01% | 2485 |
|